Repligen to Report Fourth Quarter and Full Year 2024 Financial Results
Repligen (NASDAQ:RGEN) has announced it will release its fourth quarter and full year 2024 financial results on Thursday, February 20, 2025, before market opening. The company will host a conference call and webcast at 8:30 a.m. ET on the same day to discuss business updates and financial results for the three- and twelve-month periods ended December 31, 2024.
The conference call will be available via toll-free numbers for domestic and international callers, and a webcast will be accessible through the company's Investor Relations website. Both the call and webcast will be archived for future access, with replay numbers provided for U.S., Canadian, and international callers using passcode 6188777.
Repligen (NASDAQ:RGEN) ha annunciato che rilascerà i suoi risultati finanziari del quarto trimestre e dell'intero anno 2024 giovedì 20 febbraio 2025, prima dell'apertura del mercato. L'azienda ospiterà una conferenza e una webcast alle 8:30 a.m. ET dello stesso giorno per discutere aggiornamenti aziendali e risultati finanziari per i periodi di tre e dodici mesi conclusi il 31 dicembre 2024.
La conferenza sarà disponibile tramite numeri senza costo per i chiamanti nazionali e internazionali, e una webcast sarà accessibile attraverso il sito web delle Relazioni con gli Investitori dell'azienda. Sia la chiamata che la webcast saranno archiviate per un accesso futuro, con numeri di replay forniti per i chiamanti degli Stati Uniti, del Canada e internazionali utilizzando il codice di accesso 6188777.
Repligen (NASDAQ:RGEN) ha anunciado que publicará sus resultados financieros del cuarto trimestre y del año completo 2024 el jueves 20 de febrero de 2025, antes de la apertura del mercado. La compañía llevará a cabo una conferencia telefónica y una transmisión web a las 8:30 a.m. ET el mismo día para discutir actualizaciones comerciales y resultados financieros para los períodos de tres y doce meses finalizados el 31 de diciembre de 2024.
La conferencia telefónica estará disponible a través de números gratuitos para los llamantes nacionales e internacionales, y una transmisión web será accesible a través del sitio web de Relaciones con Inversores de la compañía. Tanto la llamada como la transmisión se archivarán para acceso futuro, con números de repetición proporcionados para los llamantes de EE. UU., Canadá e internacionales utilizando el código de acceso 6188777.
Repligen (NASDAQ:RGEN)은 2025년 2월 20일 목요일에 2024년 4분기 및 연간 재무 결과를 시장 개장 전 발표할 것이라고 발표했습니다. 회사는 같은 날 오전 8시 30분 ET에 비즈니스 업데이트 및 2024년 12월 31일 종료된 3개월 및 12개월 기간의 재무 결과에 대해 논의하기 위해 컨퍼런스 콜과 웹캐스트를 개최할 예정입니다.
컨퍼런스 콜은 국내 및 국제 발신자를 위한 무료 전화번호를 통해 제공되며, 웹캐스트는 회사의 투자자 관계 웹사이트를 통해 접근할 수 있습니다. 호출 및 웹캐스트는 미래 접근을 위해 아카이브되며, 미국, 캐나다 및 국제 발신자를 위한 재생 번호가 접속 코드 6188777과 함께 제공됩니다.
Repligen (NASDAQ:RGEN) a annoncé qu'il publiera ses résultats financiers du quatrième trimestre et de l'année complète 2024 le jeudi 20 février 2025, avant l'ouverture des marchés. La société organisera une conférence téléphonique et un webinaire le même jour à 8h30 ET pour discuter des mises à jour commerciales et des résultats financiers pour les périodes de trois et douze mois se terminant le 31 décembre 2024.
La conférence téléphonique sera disponible via des numéros gratuits pour les appelants nationaux et internationaux, et un webinaire sera accessible via le site des Relations Investisseurs de l'entreprise. Tant l'appel que le webinaire seront archivés pour un accès futur, avec des numéros de rediffusion fournis pour les appelants des États-Unis, du Canada et internationaux, utilisant le code d'accès 6188777.
Repligen (NASDAQ:RGEN) hat bekannt gegeben, dass es am Donnerstag, den 20. Februar 2025, vor Eröffnung des Marktes seine Finanzergebnisse für das vierte Quartal und das gesamte Jahr 2024 veröffentlichen wird. Das Unternehmen wird am selben Tag um 8:30 Uhr ET eine Telefonkonferenz und einen Webcast abhalten, um Geschäftsupdates und Finanzergebnisse für die drei und zwölf Monate zum 31. Dezember 2024 zu besprechen.
Die Telefonkonferenz wird für inländische und internationale Anrufer über gebührenfreie Nummern verfügbar sein, und ein Webcast wird über die Investor-Relations-Website des Unternehmens zugänglich sein. Sowohl die Telefonkonferenz als auch der Webcast werden für den zukünftigen Zugriff archiviert, mit Rückrufnummern, die für Anrufer aus den USA, Kanada und international mit dem Zugangscode 6188777 bereitgestellt werden.
- None.
- None.
Webcast and Conference Call to Be Held Thursday, February 20, 2025, at 8:30 a.m. ET
WALTHAM, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its fourth quarter 2024 financial results on Thursday, February 20, 2025. The Company will issue a press release before the market opens and will host a conference call at 8:30 a.m. ET to discuss business updates and financial results for the three- and twelve- month reporting periods ended December 31, 2024.
The conference call will be accessible by dialing toll-free (844) 274-3999 for domestic callers and (412) 317-5607 for international callers. No passcode is required for the live call. In addition, a webcast will be accessible via the Investor Relations section of the Company’s website. Both the conference call and webcast will be archived for a period of time following the live event. The replay dial-in numbers are (877) 344-7529 for callers in the U.S., (855) 669-9658 for callers in Canada and (412) 317-0088 for international callers. Replay listeners must provide the passcode 6188777.
About Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. We are “inspiring advances in bioprocessing” for the customers we serve; primarily biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Our focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Our corporate headquarters are located in Waltham, Massachusetts, and the majority of our manufacturing sites are in the U.S., with additional key sites in Estonia, France, Germany, Ireland, the Netherlands and Sweden. For more information about the our company see our website at www.repligen.com, and follow us on LinkedIn.
This press release may contain forward-looking statements within the meaning of the federal securities laws. Investors are cautioned that statements in this press release which are not strictly historical statements including, without limitation, statements identified by words like “believe,” “expect,” “may,” “will,” “should,” “seek,” or “could” and similar expressions, constitute forward-looking statements. Such forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated, including risks discussed from time to time in our filings with the Securities and Exchange Commission. We expressly disclaim any responsibility to update any forward-looking statements, except as required by law.
Repligen Contact:
Sondra S. Newman
VP, Global Head of Investor Relations
(781) 419-1881
investors@repligen.com
FAQ
When will Repligen (RGEN) report Q4 2024 earnings?
What time is Repligen's (RGEN) Q4 2024 earnings call?
How can investors access Repligen's (RGEN) Q4 2024 earnings call?
What is the replay passcode for Repligen's (RGEN) Q4 2024 earnings call?
